White label ELPA - ClinicalTrials.eu

Study on the Effects of Bezafibrate and Obeticholic Acid for Patients with Primary Biliary Cholangitis

Not recruiting

2 1 1 1
Investigated Diseases:
- Primary biliary cholangitis
Investigated Drugs:
- Bezafibrate
- Obeticholic Acid
Study on Radium-223, Docetaxel, and Prednisone for Patients with Bone-Only Metastatic Castration-Resistant Prostate Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Hormone-refractory prostate cancer
- Prostate cancer metastatic
Investigated Drugs:
Study of capivasertib tablets in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Capivasertib
Study on the Effectiveness of Dornase Alfa for Improving Blood Flow in Patients with Ischemic Stroke Eligible for Thrombectomy

Not recruiting

2 1 1 1
Investigated Diseases:
- Ischaemic stroke
Investigated Drugs:
- Dornase Alfa
Study on Lacosamide and Duloxetine for Patients with Chemotherapy-Induced Neuropathic Pain

Not recruiting

3 1 1 1
Investigated Diseases:
- Neuralgia
- Polyneuropathy
Investigated Drugs:
- Lacosamide
- Duloxetine
Study of Hydroxychloroquine Effects in Patients with Resectable Head and Neck Cancer or Non-small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Head and neck cancer
- Non-small cell lung cancer
Investigated Drugs:
- Hydroxychloroquine Sulfate
Study of Pembrolizumab and Cyclophosphamide for Patients with Inflammatory Breast Cancer on the Chest Wall

Not recruiting

2 1 1 1
Investigated Diseases:
- Inflammatory carcinoma of the breast
Investigated Drugs:
- Cyclophosphamide Monohydrate
- Pembrolizumab
Study on the Effect of Adding Leuprorelin Acetate to Radiotherapy for Patients with Oligo-recurrent Prostate Cancer with Up to 4 Metastases

Not recruiting

3 1 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
- Leuprorelin Acetate
Study of Cabozantinib for Patients with Advanced Renal Cell Carcinoma Previously Treated with One Immunotherapy Drug

Not recruiting

2 1 1 1
Investigated Diseases:
- Clear cell renal cell carcinoma
Investigated Drugs:
- Cabozantinib
Study on the Safety and Effects of AMT-130 for Adults with Early Huntington’s Disease

Not recruiting

2 1 1
Investigated Diseases:
- Huntington’s disease
Investigated Drugs:
- Ifezuntirgene Inilparvovec

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies